SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-15-000064
Filing Date
2015-07-28
Accepted
2015-07-27 20:26:20
Documents
15
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q valeantq22015.htm 10-Q 2220749
2 EXHIBIT 10.1 exhibit101.htm EX-10.1 50626
3 EXHIBIT 10.2 exhibit102.htm EX-10.2 80398
4 EXHIBIT 10.3 exhibit103.htm EX-10.3 2103960
5 EXHIBIT 31.1 exhibit311.htm EX-31.1 14428
6 EXHIBIT 31.2 exhibit312.htm EX-31.2 14052
7 EXHIBIT 32.1 exhibit321.htm EX-32.1 8837
8 EXHIBIT 32.2 exhibit322.htm EX-32.2 8289
15 g63382g51k91.jpg GRAPHIC 4280
  Complete submission text file 0000885590-15-000064.txt   15509659

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT vrx-20150630.xml EX-101.INS 3534111
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrx-20150630.xsd EX-101.SCH 69118
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrx-20150630_cal.xml EX-101.CAL 112907
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrx-20150630_lab.xml EX-101.LAB 982381
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrx-20150630_pre.xml EX-101.PRE 599360
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrx-20150630_def.xml EX-101.DEF 443131
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 151008105
SIC: 2834 Pharmaceutical Preparations